Chapter 42: Care of Transgender Patients

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

Today, we are cracking open the books for one of our last minute lecture sessions.

Oh yeah.

You know that feeling, I mean, clinical rotations are maybe you just get a new patient on your schedule and you suddenly realize there's this massive gap in your knowledge base that you need to fill like yesterday.

We have all been there.

That little moment of panic, the pre -credit cram session, it's a rite of passage.

It absolutely is.

And today we're tackling a subject that is becoming increasingly vital in primary care, but, and let's just be honest here, is often a major source of anxiety for students.

A huge source of anxiety.

And not because they don't care, but because they're absolutely terrified of saying the wrong thing, using the wrong word or, or missing something just incredibly crucial.

That anxiety is so real, but I find it usually stems from a lack of exposure, you know, not a lack of empathy.

Exactly.

So today we are looking at chapter 42 from Advanced Health Assessment and Clinical Diagnosis in Primary Care.

The chapter itself is just titled Patients.

Patients.

I like that.

It's a simple title, but it, it really carries a lot of weight, doesn't it?

It does.

I think it's meant to remind us that before we get into any of the complexities, we're just, we're treating people.

So looking at the source material, our mission today is pretty specific.

We're going to decode this chapter's approach to inclusive care,

but we're not just talking about being polite.

No, no.

We're looking at symptom -based assessment, because at the end of the day, this is a health assessment text.

We need to know what to do when a patient walks in with abdominal pain or, you know, needs a cancer screening.

Right.

We really need to dig into the specific clinical reasoning that's required here.

And I do want to put a disclaimer right up front, one that the text itself makes very clear.

Okay.

This deep dive is sticking strictly to this chapter.

Yeah.

We are not covering the diagnosis of gender dysphoria.

We aren't covering the psychiatric criteria for surgery.

We're not getting into the weeds of mental health diagnosis at all.

No,

we are strictly, and I mean strictly in the realm of primary care, the sore throats, the lumps and bumps, the preventative maintenance,

the, the real nuts and bolts of the physical exam.

And that's what makes this so fascinating because the medical principles, you know, the anatomy, the physiology, those remain constant.

A kidney is a kidney.

A kidney is a kidney.

Prostate is a prostate.

It really doesn't matter who the person is.

The physiology of a kidney stone is exactly the same, but the context and application for transgender patients require a very specific set of tools.

Right.

You're going to hear us talk a lot about things like the organ inventory and the two -step history taking method.

You know, that organ inventory concept, it blew my mind a little bit when I first read it.

It seems so obvious once you hear it, but it completely rewires how you look at a patient's chart.

It forces you to stop making assumptions.

Yeah.

And in medicine, assumptions are, well, they're what get people hurt.

Oh, heavy start, but it's an accurate one.

Okay.

So before we get to the organs, we have to lay the foundation.

We have to get the terminology right.

I feel like this is where 90 % of the student anxiety lives.

They just don't want to offend anyone.

It absolutely is where the anxiety lives, but precision is so key here.

The text refers to transgender as an umbrella term in this chapter.

It's meant to be inclusive of both transgender and gender nonconforming patients.

So let's break that umbrella down.

The text gives us some very, very specific definitions.

If you're a student listening to this, you might think you know these from social media or the news, but let's be clinical about it.

Let's be precise.

First, we have gender identity.

The text defines this as an internal sense of self.

Internal.

Yeah.

It's how one fits into the world from the perspective of gender, keyword,

internal.

You cannot see gender identity on an X -ray.

It's the patient's lived reality inside their own mind.

Okay.

So contrast that with sex, because in common everyday language, people use them interchangeably all the time.

Right.

But clinically, we just can't do that.

Sex, in this context, refers specifically to the sex assigned at birth, and that assignment is based on an assessment of external genitalia, chromosomes, and reproductive organs.

So it's a biological classification.

It's a biological classification at a specific point in time birth.

The doctor looks at the baby and says, it's a boy or it's a girl.

That right there, that's the sex assignment.

So putting those two together, we get the clinical definition of transgender.

Yes.

Transgender refers to when that internal gender identification and the expression of it is different from the sex that was assigned at birth.

Okay.

And to be even more specific, a transgender man, often abbreviated as a trans man or FTM, which stands for female to male.

That's a person with a male gender identity who was assigned the female sex at birth.

And conversely, a transgender woman or trans woman, MTF, is a person with a female gender identity who was assigned the male sex at birth.

Correct.

And it's really important to get those directions right in your head because it dictates what kind of anatomy we might be looking for later in the exam.

Now, here's a word I hear a lot, and I think some people think it's, I don't know, a slur or some kind of political term, but the text treats it as a standard descriptive term, cisgender.

It is definitely not a slur.

It actually has a Latin origin.

Really?

I didn't catch that in the text.

It does.

Cis is Latin for on the same side.

Oh.

Think back to organic chemistry.

You had cis and trans isomers, right?

Trans means across or on the other side.

Cis means on the same side.

So a cisgender person is simply someone whose

gender identity and their assigned sex align.

They're on the same side.

They're on the same side.

I love that.

It just takes all the mystery and frankly, the politics out of the word.

It's just Latin.

It's chemistry.

Exactly.

It's just a descriptor.

It's a neutral way to describe the majority of the population without labeling them as normal, which then implies that everyone else is somehow abnormal.

That makes perfect sense.

But the text also gets into some more nuanced terms, things like gender expression.

How is that different from gender identity?

This is really important for the physical exam, actually.

So gender identity is what's in your head.

Gender expression is the outward manifestation of that.

What you see.

It's appearance, personality, behavior, things that are culturally defined as either masculine or feminine.

You know, clothing, hairstyle, mannerisms.

And that leads to gender role conformity, which is just how much that expression sticks to cultural norms.

Right.

The extent to which that expression adheres to those norms.

So you can have a gender identity that is male, but a gender expression that is fluid?

Or maybe non -conforming to what society expects?

Precisely.

Just because a trans man identifies as male doesn't mean he has to wear flannel shirts and grow a beard, you know, any more than a cis gender man has to.

Expression is personal.

And that brings us to the term non -binary.

Right.

This falls under that big umbrella we mentioned at the start.

Non -binary refers to a person who identifies as neither male nor female.

They might view gender as more of a spectrum rather than just a binary switch.

So you might hear other terms.

You might hear terms like genderqueer, genderfluid, or gender neutral.

For a clinician, this could be tricky, right?

Because our intake forms are usually binary.

Male checkbox, female checkbox.

Non -binary patients don't fit neatly into those boxes.

And the big takeaway for me from this whole definition section was the concept of transition.

I think a lot of people, myself included, before I really studied this, view it as a single event.

You know, like you go to the hospital on Tuesday, you have the surgery, and on Wednesday you've And the text corrects that assumption almost immediately.

Transition is a process.

A journey.

It's a journey.

It is highly, highly individualized.

It involves changing one's gender expression or sex characteristics to agree with that internal sense of self.

It might include social changes, like changing your name or your pronouns.

It might include medical changes, like hormones.

It might include legal changes, like changing your driver's license or birth certificate.

But, and this is so critical for the clinician to understand, does every single transgender person go through all of those steps?

Absolutely not.

And this is a vital point.

Not all transgender persons choose or are even able to have hormonal therapy or surgeries.

That's a huge point.

You cannot assume that because someone identifies as a transgender man, for example, that he's on testosterone or that he's had surgery.

Transition varies wildly from person to person.

Exactly.

It can range from minimal changes, like just clothing and hair, all the way to complete anatomical reconstruction.

And your assessment, your physical exam, has to be ready to handle that entire spectrum.

So you might see a trans man who has had absolutely no medical intervention, and physically his anatomy is what you'd expect for someone assigned female at birth.

Right.

And in the next room, you might see a trans woman who has had full bottom surgery and has been on hormones for 20 years.

You have to be ready for anything.

Okay.

So we know who we're talking about.

We have the terminology down.

Now we need to understand the context.

Why does this chapter even exist?

Why can't we just treat everyone the same?

The text cites a 2015 survey that, well, it paints a pretty stark reality.

It really does.

This is the why behind all the clinical guidelines.

That survey included over 27 ,000 respondents, and the data on health outcomes and disparities is heavy.

It reports incredibly high levels of mistreatment, harassment, and discrimination in pretty much every aspect of life.

Including healthcare.

Especially in healthcare.

Yeah.

But let's look at the violence statistics first, because they really inform the trauma -informed care approach that we're going to talk about later.

Okay.

Nearly half, 47 % of respondents had been sexually assaulted at some point in their lives.

47%.

That's almost one in two.

That just stops me in my tracks.

It should.

And 54 % experienced some form of intimate partner violence.

So when you, the provider, walk into an exam room, you have to know that statistically there's a very, very high chance the patient in front of you has a significant trauma history.

So if you move too fast or touch without asking.

You could be re -traumatizing them without even realizing it.

And then there's the issue of avoiding care altogether.

The survey says 23 % avoided seeking necessary healthcare in the past year.

A quarter of the population.

Why?

Just fear of mistreatment.

That's a quarter of the population not going to the doctor because they are scared of us.

Scared of the provider.

And a third of those who did see a provider reported a negative experience.

Like what?

Being refused treatment, being verbally harassed, or, and this one is very common, having to teach the provider about transgender people just to get basic competent care.

Oh man.

Can you imagine going to a cardiologist for chest pain and having to explain to them how the heart works before they can treat you?

It's exhausting for the patient.

Yeah.

And it creates a huge barrier to care.

That brings us to what I think was the real aha moment of this section for me.

There was this one specific statistic about bathrooms that connected a social issue directly to a clinical pathology.

Yes.

This is a perfect example of how social determinants directly impact physical health.

The survey found that 32 % of respondents,

they limited the amount they ate or drank, just to avoid using a public restroom.

Just because they didn't feel safe or comfortable there.

They didn't know which one to use, or they were afraid of being harassed or even assaulted.

Exactly.

And the clinical consequence of that behavior,

8 % reported having a urinary tract infection, a kidney infection, or other kidney related problems in the past year,

purely as a result of avoiding restrooms.

That is just wild.

I mean, if a patient comes into your clinic with recurrent UTIs, your first thought isn't usually, I wonder if they're chronically dehydrating themselves to avoid public bathrooms.

But in this population, it absolutely has to be on your differential.

Precisely.

It's a dehydration and urine retention issue that's driven entirely by social fear.

And we can't ignore the mental health context here either.

39 % were experiencing serious psychological distress.

That's compared to just 5 % in the general US population.

The disparity is enormous.

And the lifetime suicide rate was 40%.

40 % compared to 4 .6 % in the general population.

That is a staggering, staggering disparity.

It's a public health crisis hiding in plain sight.

It is.

So when we talk about being culturally sensitive, it's not just about being polite or using the right words.

It's about recognizing that this patient population carries a massive burden of stress, trauma, and systemic barriers that directly affect their physical well -being.

That is the definition of minority stress theory in action.

Chronic stress raises cortisol.

Cortisol affects the heart, the immune system, the metabolism.

It's all connected.

So knowing all of that, knowing the trauma, the stress, the fear, how do we even start the conversation?

How do we build trust?

The text recommends a very specific way to ask about gender.

They call it the two -step question process.

Right.

And this is considered much more effective than just asking, are you male or female, or having a single check docs.

If you just have male -female option, you lose a ton of data.

You don't know if your patient is cisgender or transgender.

So walk us through the steps.

What's step one?

Step one is, what is your gender identity?

This prioritizes who they are.

The options on your form might be male, female, transgender man, transgender woman, gender queer, and maybe a write -in option.

And step two.

Step two is, what sex were you assigned at birth?

Okay.

So identity first, then biology.

Why is order so important?

Querying gender identity first emphasizes that this is the most important factor to the person.

It validates their existence right from the start.

But then asking the assigned sex at birth establishes that biological baseline you need for that organ inventory we hinted at.

You need both.

You need both pieces of information to provide safe,

comprehensive medical care.

I can see how that might feel a little awkward to ask if you're not used to it.

It absolutely can be.

But you normalize it.

You could frame it like, in order to provide you with the best care and make sure I'm screening you for all the right things, I need to ask a couple of standard questions that we ask all our patients.

The text also puts a lot of responsibility on the provider to examine their own internal biases.

It's not just about asking the right questions.

It's not.

It says explicitly that you need to examine your own attitudes.

We all have assumptions.

We all have biases.

But in the exam room, those assumptions can be And part of checking those assumptions is using the right names and pronouns.

The text is pretty firm on this.

Failure to use the chosen name and pronoun compromises care.

It breaks the therapeutic relationship.

If you call a patient by their legal name, which might be a dead name to them, a name they associate with a past they've moved away from, instead of their chosen name, you've just signaled that you don't see them.

You've signaled that you're looking at the chart, not the person in front of you.

Exactly.

And the trust is gone.

The text suggests simply asking, what name do you go by?

And what pronouns do you use?

And then, and this is the key part, you have to record it.

Yes.

Put it in the chart, make a sticky note, put it in the preferred name field in the EMR.

Do whatever you have to do so that the next person, the nurse, the specialist you refer them to, doesn't make the same mistake.

Continuity of respect.

Continuity of respect is just as important as continuity of care.

What about talking about anatomy?

I can imagine that might be really awkward if a patient has dysphoria about certain body parts.

Like, if a trans man hates having a chest, how do you even bring up a breast exam?

Delicate navigation is required.

The text suggests mirroring the patient's language, or even better, asking for their preference.

Some patients might prefer very general terms like top and bottom surgery.

Others might be very clinical and use the anatomical terms.

So you ask them?

You ask, what terms do you prefer I use for your body parts?

And the text explicitly mentions using phrases like patients with a uterus rather than women when you're discussing medical risks.

That decouples the organ from the identity.

It does.

It's more scientifically accurate in this context anyway, and it reduces dysphoria.

If you say to a trans man, we need to check your uterus, that's an organ check.

If you say we need to do a woman's health check, that can feel incredibly invalidating.

And it's not just the doctor, right?

The text makes it clear it's the whole environment.

The whole team.

The text says inclusive care extends to the front desk staff, the phlebotomist in the lab, the x -ray technician.

If the intake forms only have male -female boxes, that's a barrier.

If there isn't a gender -neutral bathroom.

That's a barrier.

And as we just learned, a potential health risk.

If the front desk person calls out Mr.

Jones from the waiting room when the patient is presenting as female and goes by Ms.

Jones, the visit has failed before you walked in the room.

Okay, so let's move into the clinical meat and potatoes.

We've done the introduction.

We've got the history started on the right foot.

Now we need to figure out what anatomy we're actually treating.

This is where that organ inventory comes in.

The text presents this as the central framework for the physical assessment of a transgender patient.

It really is the central framework.

In a cisgender patient, you rely on heuristics, on shortcuts.

You assume man equals prostate, penis, testes, woman equals uterus, ovaries, vagina, breasts.

You don't even have to think about it.

But in this population, you absolutely cannot assume.

You cannot.

You must maintain an inventory.

It's a mental or better yet, a physical checklist in the chart.

What organs are present?

Are they natal, meaning the ones they were born with, or are they surgically constructed?

And just as importantly, what has been removed?

Because you can have a transgender man who still has a uterus and ovaries.

Exactly.

Or a transgender woman who still has a prostate.

And if you don't know an organ is there, you can't screen it for cancer.

And you can't diagnose it if it gets infected or causes pain.

So to build this inventory, we need to ask about surgeries.

The text has a great table, box 42 .2, that lists the common gender -affirming surgeries.

Let's maybe unpack some of these because some terms might be new to our listeners, or they might know the slang but not the medical terminology.

Let's start with feminizing surgeries for trans women, so MTF.

Sure.

I think one of the major ones that comes to mind is vaginoplasty.

That's the surgical creation of a neovagina.

Yeah.

Usually this involves using skin from the penis and scrotum to create a vaginal canal and an external vulva.

We'll talk about the exam implications of that later because the anatomy is really unique.

Okay.

Breast augmentation.

That one seems pretty straightforward.

Right.

Standard implants, very similar to procedures for cisgender women.

Archaeectomy.

That's the removal of the testicles.

This is a big one medically because it removes the body's primary source of testosterone.

So that makes the other hormones more effective.

Much more effective.

It allows the estrogen therapy to work without having to fight against the testosterone.

It also means they can often lower the dose of any anti -androgen medications they're on, which reduces side effects.

And then there are procedures that I think people might immediately think of as medical in the same way, but are just huge for gender affirmation.

Facial feminization surgery.

This is incredibly complex surgery.

It can involve things like bone shaving of the brow ridge, jaw contouring, rhinoplasty, all sorts of soft tissue work.

It literally changes the bone structure of the face to appear more feminine.

And what about the tracheal shave?

The medical term is reduction thyrochondroplasty.

It's a procedure that reduces the size of the apple,

the thyroid cartilage.

It's considered cosmetic, but for many trans women, it's vital for their safety and ability to pass in society.

And vocal cord surgery.

Yes, there are surgeries to raise the pitch of the voice.

They can shorten or tighten the vocal cords to achieve that.

Okay, let's slip to the other side.

Masculinizing surgeries for trans men, FTM.

Top surgery is probably the most common.

That's masculinizing chest surgery.

So a mastectomy.

It's a mastectomy more.

It also involves chest contouring to create a flat masculine chest.

It's not just a reduction, it's a total reconstruction of the chest wall aesthetic, often including resizing and repositioning the nipples.

And for the internal reproductive organs?

There will be a hysterectomy, which is removal of the uterus, and an oophorectomy, which is removal of the ovaries, sometimes done together, sometimes separately.

Now, what about genital reconstruction?

I see two main terms here,

phalloblast and metoidioplasty.

What is the difference between those two?

This is a really common point of confusion.

Phalloplasty is the surgical creation of a new penis or neopenis using tissue graphs.

Graphs from where?

Usually from the forearm.

That's a radial forearm flap or from the thigh.

The goal is to create a phallus of a size typical for an adult.

It's a very complex multi -stage surgery.

And metoidioplasty, how is that different?

Metoidioplasty is a different approach.

It actually relies on the growth that's caused by testosterone therapy.

Okay.

Testosterone causes the clitoris to enlarge significantly.

That's called clitoromegaly.

Metoidioplasty is a surgery that releases the enlarged clitoris from its surrounding ligaments.

This allows it to extend further out from the body, acting as a small penis or a microphallus.

Does it?

Does it function like a penis?

It retains sensation very well, which is a major advantage.

The surgery often includes urethral lengthening so the patient can stand to urinate.

It doesn't have the size of a phalloplasty, but it has far fewer complications and preserves natal sensation.

Got it.

Okay, so that's the surgical side of the inventory.

But a lot of patients are managing their transition primarily or even exclusively through hormones.

Box 42 .3 in the text breaks down these therapies.

This is pharmacology time.

Hormone therapy is a massive part of this.

The goal is to suppress the natal secondary sex characteristics and promote the of characteristics aligned with the patient's gender identity.

It's like a second puberty.

It is exactly a second puberty.

And the text notes that the physical changes generally occur over a course of about two years.

It's not an overnight thing.

Let's talk about that timeline because it's not instant.

Definitely not.

The speed and extent of changes depend on the dose,

the route of administration, you know, patch versus pill versus injection, and the patient's age and genetics.

Let's look at feminizing therapies first.

This is for trans women.

It usually involves estrogen and an anti androgen like spironolactone.

What are the effects we're looking for?

The text breaks them down into irreversible and reversible effects.

This is absolutely crucial for informed consent before starting therapy.

So what's irreversible?

Irreversible effects include breast tissue growth and decreased testicular volume.

Even if you stop the hormones five years later, that breast tissue stays.

You would need surgery to remove it.

And the reversible effects?

That would be fat redistribution.

So getting that more feminine shape in the hips, thighs and face,

softer skin,

decreased muscle mass, and decreased libido.

If you stop the hormones, the fat will tend to migrate back to a more male pattern and muscle mass will return.

And as a clinician, what are the risks?

What am I watching for in their labs or their history?

Estrogen carries a risk of venous thromboembolism or VTE blood clots.

This is the big scary one.

If a trans woman on estrogen comes into the ER with calf pain or sudden shortness of breath, you have to have DVT or PE high on your differential.

What else is on the list?

Gallstones, elevated liver enzymes, because the liver has to process all these hormones, weight gain, and potentially an increased risk of cardiovascular disease.

And the spironolactone?

Spironolactone is a diuretic that is potassium sparing.

So you have to watch their labs for hyperkalemia high potassium.

Okay.

Now let's switch to masculinizing therapies for trans men.

Primarily that's T.

So what are the irreversible effects of T?

The big one is voice deepening.

Testosterone thickens the vocal cords.

Once that larynx changes and the voice drops, it doesn't go back up.

Even if they stop T, the voice stays deep.

What else?

Facial and body hair growth, the clitoral enlargement, the clitoromidly we talked about.

And for those with a genetic predisposition, male pattern balding.

Wait, balding is irreversible.

Once that hair is gone, it's gone.

If they have the genes for baldness from either side of their family, T will activate them.

And the reversible effects of testosterone?

Increased muscle mass and strength.

Acne acne is a huge one.

It really is puberty all over again.

Redistribution of body fat away from the hips into the abdomen.

And of course, cessation of menses.

Usually periods will stop within about six months of starting therapy.

And the risks for testosterone?

The main one to monitor is polycythemia.

Thick blood.

Right, too many red blood cells.

Testosterone stimulates erythroesis, the production of red blood cells.

If the hematocrit gets too high, the blood gets viscous and the risk of stroke or heart attack goes way up.

That's why you have to monitor their hematocrit regularly.

What else?

Again, elevated liver enzymes.

Worsening of lipid profile, so higher LDL, lower HDL.

And sleep apnea testosterone can change the structure or muscle tone.

And the increase in neck mass can definitely worsen or even cause sleep apnea.

The text also emphasizes that fertility is a major conversation that needs to happen before starting any hormones.

Yes.

For trans men, testosterone significantly decreases fertility.

But, and we need to shout this from the rooftops, it does not eliminate the possibility of pregnancy.

Say that again for the people on the back.

Yeah, testosterone is not birth control.

If a trans man has a uterus and ovaries and having penetrative sex with a partner who produces sperm, he can get pregnant.

Even if he hasn't had a period in a year.

Even if he hasn't had a period in a year.

Ovulation can still occur sporadically.

It is a vital clinical pearl.

It is.

I want to touch on the section about adolescence because it's so relevant now.

The text mentions tuberous suppression.

This is a hot topic, but let's just stick to the medical mechanism here.

Right.

The medications used are GnRH agonists.

That's gonadotropin -releasing hormone agonists.

The easiest way to think of this is as a pause button.

A pause button on puberty?

How does it work?

It essentially overstimulates and then desensitizes the pituitary gland so it stops producing LH and FSH.

Without those hormonal signals from the brain,

the gonads, the tests, or ovaries don't get the message to produce sex hormones.

So no testosterone, no estrogen.

And who is this for according to the text?

This is for an adolescent at what's called tanner stage two.

That's the very, very beginning of And what's the clinical benefit of hitting that pause button?

The benefit is that it stops the development of those irreversible secondary sex characteristics we just talked about.

No permanent beard growth, no breast growth that would later need surgery,

no voice deepening, no permanent widening of the hips.

It buys time.

Time for what?

It allows the patient and their family and their mental health team time to explore their identity without the constant pressure and distress of their body changing in a way they don't want.

And is it a permanent change?

No.

And this is a critical distinction.

It is fully reversible.

If they stop the blockers, the pituitary wakes up and puberty resumes exactly where it left off.

So it's a delay, not a dilution.

That's important.

But there's another category of substances the text warns us about on the other end of the spectrum.

Unlicensed substances.

Specifically,

silicone injections.

This is a really serious health risk.

Some transgender women, perhaps because they lack access to traditional medical care or maybe they want faster, more dramatic curves than hormones alone can provide, use silicone or other soft tissue fillers.

With their breasts or hips.

Right.

To enhance that contour.

And this isn't getting a little bit of Juvederm at a licensed dermatologist's office.

No.

The text calls this pumping.

It's often done by unlicensed providers at what are called pumping parties.

The silicone might not be medical grade.

It could be industrial silicone from a hardware store.

It might be mineral oil.

It could be anything.

Yikes.

And the risks are incredibly severe.

The silicone is free -floating in the tissue.

It can migrate.

We're talking about silicone injected in the hips, moving all the way down to the ankles.

It can enter the bloodstream and cause a silicone embolism to the lungs, which is often fatal.

And what about locally in the tissue?

Locally, it causes granulomas.

These are hard, painful, inflammatory lumps where the immune system tries desperately to wall off this foreign body.

It can cause severe inflammation, chronic pain, disfigurement, or act as a massive non -healing foreign body infection.

So if a patient presents with breast pain or hard lumps and has a history of pumping, your entire differential diagnosis has to shift.

Immediately.

It's not just mastitis or simple cyst.

You're dealing with a major foreign body reaction.

It's really a tragic consequence of the barriers many people face in getting safe, affirming care.

It is.

Okay, let's shift gears now to the psychosocial history.

We've covered the biology, the hormones, the surgeries, but the text is very clear that you have to ask about the life of the patient outside the clinic walls.

You have to screen for safety.

You have to ask about employment discrimination, about housing instability.

Transgender people face enormous rates of homelessness and underemployment.

You need to ask, do you have a safe place to live?

And support systems.

The text makes a really interesting differentiation between family and chosen family.

Chosen family.

Tell us about that.

Well, often the biological family of origin is not supportive, or in some cases, has completely rejected them.

But the chosen family, that's friends, partners, other community members, that is their lifeline.

That's the real support system.

And knowing who they rely on is crucial for things like discharge planning or emergency contacts.

And there are also specific gender -affirming practices that are not medical or surgical, but they have real medical consequences.

These are things patients might do on a daily basis to align their physical appearance with their identity.

Right.

And you have to ask about them because they cause symptoms.

If you don't know the patient is doing it, you won't be able to diagnose the problem correctly.

So let's run through the main ones, the text lists.

First up, binding.

This is primarily used by trans men.

It's the practice of compressing the chest tissue with things like tight sports bras, ace bandages, or specially made binders to create a flat chest contour.

And what are the clinical risks of that?

Skin breakdown is a big one.

Fungal infections.

It gets hot, dark, and sweaty under a binder.

Back pain from the compression.

Even rib fractures if it's way too tight or worn for too long.

And restricted breathing.

The text also notes that some patients might be really reluctant to remove the binder for a chest or lung exam because of dysphoria.

So how do you handle that in the exam room?

You negotiate.

You acknowledge their discomfort.

I understand you prefer to keep the binder on, but to listen to your lungs properly and check that rash, I really need you to lift it or remove it just for a moment.

I will be as quick as possible and you can put it right back on.

Next on the list is packing.

Also primarily used by trans men.

This is wearing a penile prosthesis in their underwear to create a bulge.

Any clinical risks there?

Usually fewer clinical risks here.

Mostly just skin irritation.

It's rubbing against the skin, so contact dermatitis.

But it's really important to know it's there so you're not surprised during an abdominal or hernia exam if you brush against it.

And then there's tucking.

This is used by trans women to create a flat crotch contour.

It involves pushing the testicles, if they're present, up out of the scrotum and into the inguinal canals.

The inguinal canals.

That sounds extremely uncomfortable.

It can be.

That's the canal the testes descended from during fetal development.

Then they position the penis and the empty scrotum posteriorly, essentially tucking it between their legs.

They might use very tight underwear, a special garment called a gaff, or even tape to hold everything in place.

Duck tape.

Yes.

Ouch.

The clinical risks are very real.

Urinary retention, if it's too tight, it can compress the urethra and they can't pee.

Hernias, because you're constantly manipulating and stretching that inguinal canal and widening the ring.

Skin breakdown and infections from the tape.

Just purely traumatic testicular pain from the positioning.

If a trans woman comes in with groin pain, you have to ask about her tucking habits.

And finally, the text mentions voice modulation.

This is just altering the pitch and resonance of the voice through sheer muscular effort.

So a trans woman trying to speak in a higher pitch, or a trans man trying to speak in a lower one, before hormones take effect.

Like trying to talk in a falsetto or a deep voice all day long.

Exactly.

And that causes vocal fatigue.

The throat can get sore, the voice can get raspy and hoarse.

It's not a strep throat, it's a muscle strain.

This deep dive is really highlighting how being a good medical detective requires knowing all these lifestyle details.

You'll misdiagnose that sore throat if you don't know they are modulating their voice.

Precisely.

You'll just keep prescribing antibiotics for a sore throat that is actually a gym injury of the vocal cords.

Okay, we're at section seven in our outline.

Cancer screening.

This is the part where that organ inventory we talked about becomes the absolute golden rule.

The golden rule.

You screen based on the organs that are present, not based on the gender identity or the appearance of the patient.

So let's break it down by population, like the text does in box 42 .5.

Let's start with transgender woman.

Okay, if they have a prostate, it needs to be screened for cancer according to standard guidelines.

Wait, wait, trans women still have a prostate even after gender -affirming surgery?

Yes, this is a huge misconception.

Even after a vaginoplasty, the prostate is almost always left in place.

Removing it is extremely risky.

It's wrapped around the urethra and near the bladder stinker.

And removing it carries a very high risk of permanent urinary incontinence.

So they leave it.

So they can still get prostate cancer.

They absolutely can.

But here's the clinical catch.

The PSA, the prostate -specific antigen test, is driven by androgens like testosterone.

And a trans woman on feminizing hormones has very low testosterone.

So her PSA level should be very, very low, close to zero.

A normal PSA reference range for a cis man might be up to 4 .0.

But for a trans woman on estrogen, a PSA of, say, 2 .0 might actually be dangerously high for her.

The text says PSA may be unreliable, and you have to interpret it with extreme caution.

So you can't just rely on the blood test.

You need a DRE, a digital rectal exam.

And if they've had a vaginoplasty, the text notes that the prostate is now anterior to the neovaginal wall.

So a digital neovaginal exam might actually be a more effective way to palpate the prostate than a rectal exam.

That is a fascinating clinical pearl.

Palpating the prostate through the vagina.

It's just anatomy, the location of the organ relative to the structures around it.

What about breast cancer screening for trans women?

If they have been on estrogen for more than five years, the risk goes up because estrogen stimulates breast tissue development.

The general recommendation in the text is to start mammograms after age 50 if they have five or more years of hormone exposure.

Okay, let's switch to transgender men.

If the cervix is intact, meaning they have not had a hysterectomy, they need regular pap smears to screen for cervical cancer, just like any other person with a cervix.

Now this seems straightforward, but the text points out a massive logistical pitfall here related to our electronic medical records and computer systems.

Ah, the lab alert.

This is huge.

If you, the provider, collect a cervical swab for a pap smear, but the patient's gender marker in the electronic medical record is listed as male.

The computer just explodes.

The computer might just flag it as an error and discard the sample.

Error, cervical sample received on male patient.

It makes it a mistake.

Or even worse, it might run the sample as an anal pap smear, which uses different benchmarks and processing for what's considered abnormal.

So the provider has to actively intervene to prevent this.

You must.

You have to alert the pathologist.

You write on the lab rack, this is a cervical sample.

Patient is on testosterone.

That context is vital for interpreting the cells too, because testosterone causes atrophic changes to the cervical cells.

It makes them look a bit abnormal, which can mimic dysplasia or pre -cancer.

The pathologist needs to know this is a testosterone effect, not cancer.

And breast cancer screening in trans men.

You follow the standard guidelines for any remaining breast tissue until they have a mastectomy.

And even after a mastectomy, there is always some small amount of chest tissue left behind.

It still requires a clinical chest wall exam.

This leads us perfectly into the physical examination section.

We've touched on some of this, but let's talk about the general approach.

The text says something that seems obvious, but probably needs to be said.

The exam should be relevant to the presenting complaint.

Right.

Don't be voyeuristic.

If a transgender patient comes in for a migraine headache,

you do not need to examine their genitals.

Period.

Does that really happen?

It happens more than you would think.

Provider curiosity is not a valid reason for an exam.

So if the exam is relevant, what are some of the things we're looking for?

Let's talk about those secondary sex characteristics.

You're looking for where they are on that hormone timeline we discussed.

For a trans man on T, you might see acne on the face or back.

You might see clitoromegaly.

And for a trans woman on estrogen.

You'll see breast development.

And note the terminology here.

The text is very clear.

Do not call this gynecomastia.

Why not?

Gynecomastia implies a pathologic breast development in a male.

In a trans woman, breast growth is the desired therapeutic effect.

It is breast tissue.

Calling it gynecomastia is clinically inaccurate and frankly insulting.

And you might see testicular atrophy.

Yes.

The testicles will be smaller or may have retracted.

Okay.

Let's talk about the pelvic exam.

This seems like it would be the most technically different part of the assessment.

It absolutely is.

Let's start with trans women who have had a vaginoplasty.

We need to really understand the anatomy of the neovagina.

It's surgically created.

Right.

Usually from penile and scrotal skin.

It ends in what's called a blind cuff.

There is no cervix.

There are no fornices.

Those are the little pockets around the cervix in a natal vagina.

In lubrication.

This is crucial.

It does not self -lubricate.

The tissue doesn't have Bartholomew's glands.

There are some rarer surgical techniques that use a segment of colon and that does self -lubricate, but it's not the common procedure.

So for the exam.

You must use a lot of lubricant.

A lot of it.

Do not attempt a speculum exam without generous lubrication.

You also need to know that the angle of the neovagina might be more posterior pointing more towards the back than a natal vagina.

And what about the pelvic exam for trans men?

If they're on testosterone, they are in a hypoestrogenic state.

It's very similar to menopausal in a cisgender woman.

The vaginal tissue becomes atrophic.

That means it's thin, dry and friable, which means it tears and bleeds easily.

Which makes the speculum exam.

Painful.

Potentially very, very painful.

The speculum stretches tissue that has lost all of its natural elasticity and lubrication.

So how do we mitigate that?

How do we make it possible to do the exam?

The text really emphasizes a trauma -informed approach here.

First, acknowledge that this might be difficult or painful.

Use a pediatric -sized speculum, which is much smaller.

Use plenty of lubricant.

And most importantly, offer the patient choices.

Choices?

Like what?

Like, would you be more comfortable if you insert the speculum yourself?

Or would you like to collect your own swab for the STI test?

Self -swabbing actually works.

Yes.

Studies have shown that self -collected vaginal swabs for things like chlamydia and gonorrhea are just as accurate as provider -collected ones.

Giving that element of control back to the patient can make the difference between a successful exam and a traumatic one.

And what if they just refuse the speculum exam altogether?

Then you respect it.

Unless at a life -threatening emergency, you respect their no.

You can offer alternatives, like a blind vaginal swab without a speculum or just a bimanual exam.

You start small, you build trust.

Maybe you don't get the pap smear this year, but you've built a relationship so maybe you can get it next year.

We're entering the homestretch here.

Section 9, differential diagnosis.

This is where we put all the pieces together, the medical detective segment.

This is the final exam.

This is where we see if you've been paying attention to all the details.

Okay, scenario one from the text.

A patient presents with breast pain.

If it's a trans man,

is it the binder?

Is it too tight?

Is there a skin infection like a fungal rash underneath it?

Or is it purely musculoskeletal pain from the constant compression?

If it's a trans woman,

does she have a history of those illicit silicone injections?

Could this be inflammation?

Is it a granuloma?

Or is it simply the normal pain of breast tissue growing, growing breasts hurt?

Scenario two, pelvic pain in a trans man.

Could be that vaginal atrophy from the testosterone causing dryness and irritation.

The change of the vaginal pH from testosterone also increases the risk of bacterial vaginosis, which can cause discomfort.

Or is it uterine cramping?

Sometimes testosterone can cause the uterine muscle itself to have spasms.

Scenario three, vaginal bleeding in a trans man who is on testosterone.

First, you check the timeline.

Mences usually stops within six months.

If it's been longer than that, or if it stops and then restarts, that's abnormal bleeding.

It could be endometrial atrophy.

The uterine lining gets so thin from the testosterone that it just cracks and bleeds.

But what is the one life -threatening thing you must rule out?

Pregnancy.

Pregnancy.

If there's a uterus and ovaries and there has been sperm exposure, pregnancy is possible.

Do not assume testosterone is a contraceptive.

An ectopic pregnancy is a medical emergency.

You must check a beta HCG.

Scenario four, scrotal pain in a trans woman.

You have to think about tucking.

Could it be epididymitis from the reflux of urine into the epididymis because of the awkward positioning?

Could it be an inguinal hernia from pushing the testicles up?

Could it be a testicular torsion from twisting the testicle to get it up into the canal?

The text also notes that tucking can position the urethra closer to the anus, increasing the risk of UTIs.

And finally, a patient comes in with voice issues.

You have to differentiate between the vocal fatigue of modulation, that muscular strain from forcing the pitch, versus an actual infection like strep throat or laryngitis.

The history is key.

Have you been practicing your voice training more than usual lately?

It is just fascinating how every single one of these differential diagnoses connects directly back to understanding the patient's lifestyle and their gender -affirming practices.

You cannot diagnose these patients correctly if you don't understand the context of their transition and their daily life.

So we've reached the end of the chapter.

Let's try to summarize this.

What are the big essential takeaways for the learner listening to this?

For me, it really boils down to two core principles.

One,

anatomy dictates care.

You must know what organs are in the body to screen them and to treat them.

You have to use that organ inventory.

Do not guess, do not assume, ask.

And the second one?

Two, respect dictates the interaction.

Use the two -step history method.

Use the chosen name and pronoun.

Be aware of the high rates of trauma and approach every exam with that in mind.

And I'll add a final thought that really struck me reading this.

The chapter is titled Patients.

Not special patients or complex patients, just patients.

And reading it highlights how much standard care often relies on shortcuts and assumptions.

We see someone who presents as a man.

We automatically think prostate.

We see someone who presents as a woman.

We think cervix.

This patient population forces a clinician to stop using those shortcuts.

It does.

It forces you to be more precise, to ask the fundamental questions.

What organs do you have?

How does your life affect your body?

What matters most to you in your care today?

And that precision, that attentiveness, that makes you a better provider for every single patient you see, whether they're cisgender or transgender.

If you can learn to communicate this clearly and respectfully with a trans patient, you will communicate better with everyone.

You'll stop making assumptions about all of your patients.

And that really is what makes a master clinician.

And that is a great place to leave it.

Thank you so much for listening to this last minute lecture, Deep Dive.

Good luck with your studies.

We'll see you next time.